Clinical Trials Arena on MSN
Gene editing takes centre stage in FDA’s new rare disease approval pathway
The aim of the pathway is to remove red tape for bespoke therapies designed for patients with rare diseases.
Crispr’s ability to cut genetic code like scissors has just started to turn into medicines. Now, gene editing pioneer ...
CNBC's Becky Quick reports on the progress of KJ Muldoon, the first patient to receive a personalized CRISPR-based gene editing therapy.
NAFDAC has raised an alert over a suspected revalidated batch of SMA Gold First Infant Milk Formula (900g) reportedly found ...
WISN 12 News on MSN
FDA proposes new system for approving customized drugs and therapies for rare diseases
Federal health officials on Monday laid out a proposal to spur development of customized treatments for patients with hard-to ...
New FDA guidelines for personalized genomic drug development are a step forward in advancing new therapies for ultrarare diseases, but industry leaders need further clarification.
Kit Harington as Sir Henry Muck, Max Minghella as Whitney Halberstram on Industry season 4 episode 6 Editor's note: This article contains spoilers for episode 6 ("Dear Henry") of Industry season 4, ...
After teasing a new regulatory process for personalized genetic medicines at the end of last year, the FDA today unveiled draft guidance for an approval pathway that could see custom CRISPR therapies, ...
Publishing giants like Penguin Random House and Macmillan are eager to use AI internally—but not for writing or editing. Their authors still might revolt.
University of Saskatchewan alum now works on major productions while carrying prairie roots forward When Samantha Letendre ...
The series about a London investment bank shows off grand ambitions this season ...
The popular baby brand is being criticized online after Instagram posts from five years ago resurfaced. Now, Frida says it's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results